tiprankstipranks
Takeda Pharmaceutical Company (TAK)
NYSE:TAK
Want to see TAK full AI Analyst Report?

Takeda Pharmaceutical Company (TAK) Revenue

1,353 Followers

Takeda Pharmaceutical Company Revenue

Takeda Pharmaceutical Company had a revenue of 1.11T in the quarter ending Mar 31, 2026, with -8.12%. This bring the company's revenue in the last twelve months to 4.55T, Decreased 1.37%. In the fiscal year ending Mar 31, 2026, Takeda Pharmaceutical Company had annual revenue of 4.78T with 4.28% growth.
Revenue (ttm)
4.55T
Revenue Growth
-0.47%
P/S Ratio
0.01
Revenue/Employee
$96,943,046
Employees
49,281
Market Cap
$52.43B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Mar 31, 2026
4.78T195.90B+4.28%
Mar 31, 2025
4.58T317.79B+7.45%
Mar 31, 2024
4.26T236.28B+5.87%
Mar 31, 2023
4.03T458.47B+12.85%
Mar 31, 2022
3.57T371.19B+11.61%
Mar 31, 2021
3.20T-93.38B-2.84%
Mar 31, 2020
3.29T1.19T+56.93%
Mar 31, 2019
2.10T326.69B+18.45%
Mar 31, 2018
1.77T